SNCA and Parkinson disease: Administering MSC-derived conditioned medium (MSC-CM) effectively reduced Iba-1 and CD4 levels, inhibited alpha-synuclein production, increased tyrosine hydroxylase levels in the striatum, and improved motor deficits in rats with rotenone-induced Parkinson’s disease.